IFRX InflaRx Total Debt to Capital
German biopharmaceutical developer InflaRx N.V. (IFRX) focuses on developing C5a antibodies for the therapy of severe inflammation and rare pathologies, currently conducting final clinical trials. This chart of share prices on GURU.Markets demonstrates a total debt-to-equity ratio of 0.01. The company's financial stability relies on current sales of treatments for viral complications and the upcoming launch of innovative drugs.
Analytical breakdowns and data insights for company InflaRx (IFRX)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:IFRX - InflaRx N.V.
Within the biotechnology sector, InflaRx N.V. focuses on attracting Germany's leading immunologists, which requires sustainable funding for R&D processes. By analyzing the total liabilities-to-equity ratio, an investor assesses the proportion of borrowed funds within the balance sheet structure, where an increase in the metric indicates credit risks, while its minimum reflects conservative capital management to preserve scientific independence.
Main competitors
Debt to Equity argenx ARGX|Aggregate Debt to Equity BioNTech Inc.|Abivax SA (ABVX) - Total Debt to Capital|All Debt to Shareholders' Equity Ratio ADMA Corp (ADMA)|Total Debt to Capital PTGX (Protagonist Therapeutics)|immunovant.com - Total Debt to Capital|Debt to Equity Kiniksa (KNSA)|GRFS: All Debt to Shareholders' Equity Ratio|ADPT (Adaptive Biotechnologies Corp) - Debt to Equity|Celldex Corp (CLDX) - Total Debt to Equity Ratio|AUPH (Aurinia Pharmaceuticals) - Total Debt to Capital|Total Debt to Capital biocryst.com (BCRX)|Vera Therapeutics (VERA) - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio Dianthus Therapeutics Inc (DNTH)|Total Debt to Capital PHVS|AbCellera - Total Debt to Capital Coefficient|TRML: Debt to Equity|PGEN: Total Debt to Equity Ratio|PHAR (Pharming Group) - Debt to Equity|Total Debt to Equity Ratio Nektar Therapeutics Inc|UPB (Upstream Bio Corp) - Total Debt to Equity Ratio|Total Debt to Capital ZBIO|Debt to Equity Immunome, Inc. IMNM|Debt to Equity Ratio gossamerbio.com (GOSS)|KALV: Total Debt to Capital|Debt to Capital Septerna, Inc. SEPN|Total Debt to Capital PVLA (Pieris Pharmaceuticals Inc)|SVRA: Total Debt to Capital Coefficient|Debt to Equity Rigel Pharmaceuticals|anaptysbio.com (ANAB) - Debt to Equity Ratio|Total Debt to Capital Astria Therapeutics, Inc. ATXS|Aggregate Debt to Equity ENGN|Debt to Equity RAPT Therapeutics, Inc. (RAPT)|Debt to Equity aerovatetx.com (JBIO)|Total Debt to Capital ACRS (Aclaris Therapeutics)|kyvernatx.com - Total Debt to Capital|Debt to Equity Tiziana Life Sciences Ltd (TLSA)|Cabaletta Bio Inc. (CABA) - All Debt to Shareholders' Equity Ratio|Total Debt to Equity Ratio Ventyx Bio|Debt to Equity Ratio Theratechnologies, Inc|AVTX - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio ELDN|Debt to Equity Agenus Inc. AGEN|Debt to Equity Ratio Climb Bio Inc. CLYM|Total Debt to Equity Ratio ZURA|ATYR - Total Debt to Capital Coefficient|ADAG - Total Debt to Equity Ratio|ImageneBio Inc (IMA) - Debt to Equity|shattucklabs.com - Total Debt to Equity Ratio|Equillium (EQ) - Total Debt to Capital Coefficient|CNTB: Total Debt to Capital|Total Debt to Capital Coefficient Immunic Inc|ATRA - Total Debt to Capital|Aggregate Debt to Equity XFOR (x4pharma.com)|Debt to Equity Adicet Bio, Inc.|CELU - All Debt to Shareholders' Equity Ratio|INmune Bio Corp (INMB) - Total Debt to Equity Ratio|BRNS: Debt to Equity Ratio|Debt to Equity Kezar Life Sciences (KZR)|sabbiotherapeutics.com (SABS) - Aggregate Debt to Equity|AKTX - Total Debt to Capital|All Debt to Shareholders' Equity Ratio Enlivex Therapeutics, Ltd.|Total Debt to Capital QTTB|Total Debt to Capital GOVX (GeoVax Corp)|Debt to Equity Edesa Biotech, Inc.|ibioinc.com - All Debt to Shareholders' Equity Ratio|CARM: Debt to Equity|XTLB - Total Debt to Equity Ratio|BOLT: Total Debt to Capital|Total Debt to Capital HCW Biologics|APVO - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio AIM ImmunoTech, Inc.|ADTX (Aditxt) - Total Debt to Capital|Total Debt to Capital Coefficient GRI (GRI Bio Inc)|XORTX - Debt to Equity|Vyome Therapeutics - Total Debt to Equity Ratio|REVB: Debt to Equity|indaptusrx.com (INDP) - Total Debt to Equity Ratio|SCNI: Total Debt to Equity Ratio|CALI (CalciMedica) - Total Debt to Capital|Debt to Equity Affimed NV (AFMD)|Debt to Equity Ratio Allakos Therapeutics|HOOKIPA Pharma Inc. - Total Debt to Capital|Debt to Capital igmbio.com (IGMS)|Total Debt to Capital ITOS|Ocean Biomedical Inc - Total Debt to Capital Coefficient|TC BioPharm (Holdings) PLC (TCBP) - Debt to Equity|THRD - Debt to Equity Ratio